🫒 EU Regulation 432/2012 • Oleocanthal Phytochemistry

Mediterranean Olive Oil & Polyphenol Dosing Calculator

Calculate your daily Extra Virgin Olive Oil intake according to the official EU Health Claim 432/2012. Discover hydroxytyrosol yield, LDL lipid protection, and natural oleocanthal anti-inflammatory potency.

🛡️
Nutritional Science Reference: Commission Regulation (EU) No 432/2012 confirms that 5 mg of hydroxytyrosol and its derivatives per 20 g of olive oil protects blood lipids from oxidative damage. This tool estimates dietary bioactive intake from raw, unheated EVOO.

Olive Oil Quality & Serving

Bioactive Dosing
Early green harvest olives picked in September/October possess a distinctly peppery back-of-the-throat tickle caused by pure oleocanthal.
0.5 tbsp 1 tbsp 2 tbsp (Standard) 3 tbsp 4 tbsp (Therapeutic)
Daily Hydroxytyrosol & Polyphenol Yield
9.6 mg/day
✅ Meets EU 432/2012 Health Claim (192% of target)
Est. Oleocanthal Intake 5.8 mg
Natural COX Inhibition ~9% Ibuprofen eq.

Cardiometabolic & Longevity Impact

🛡️ LDL Lipid Oxidation Protection: 96% Optimal
🌱 Vascular Endothelial Nitric Oxide Support: 88%
🥄 Optimal Ingestion Rule: Consume this olive oil raw by drizzling it directly over warm roasted vegetables, legume soups, or toasted sourdough after cooking. Heat exceeding 180°C oxidizes delicate secoiridoids and degrades oleocanthal potency.

Phytochemical Profile: Hydroxytyrosol & Oleocanthal

Extra Virgin Olive Oil (EVOO) is a cornerstone of the Mediterranean diet. Beyond its monounsaturated oleic acid matrix, its therapeutic efficacy stems from complex secoiridoid polyphenols:

Commission Regulation (EU) 432/2012: Established that 5 mg of hydroxytyrosol and its derivatives per 20g of olive oil protects circulating LDL particles from oxidative modification—the initiation step in atherogenesis.
Beauchamp et al. (Nature, 2005): Discovered that (-)-oleocanthal naturally inhibits cyclooxygenase enzymes (COX-1 and COX-2) identically to the non-steroidal anti-inflammatory pharmaceutical ibuprofen.
PREDIMED Landmark Trial: Estruch et al. (NEJM, 2018) demonstrated that 4 tablespoons (50g) of extra virgin olive oil daily reduced major cardiovascular events by 30% over 4.8 years of follow-up.